ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs
ATCC announced a seven-year contract, with an initial award of over $21.5 million, from NIAID to continue the management of the newly merged NIH HIV Reagent Program with the BEI Resources Program.
November 28, 2023
ATCC Announces Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) Award from NIAID
ATCC was awarded a Task Order under the Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) to manage critical biomaterials for NIAID's Vaccine Research Center.
ATCC Products to be Used in Microgravity Experiments on the International Space Station
ATCC catalog item MSA-2003-ISS was sent to the International Space Station (ISS National Lab) aboard the SpaceX CRS-29 mission.
November 07, 2023
ATCC Announces Award from NIAID to Support Its Preclinical Services for Biopharmaceutical Product Development
ATCC awarded an IDIQ contract by NIAID to support its preclinical services for biopharmaceutical product development.
November 02, 2023
ATCC Appoints Dr. Alfredo Molinolo to Its Board of Directors
Dr. Molinolo's strong research background and extensive expertise in pathology, oncology, and histotechnology will make him a tremendous asset to ATCC.
ATCC and USP Launch First Set of Products to Advance Quality and Reduce Risk in the Development of Biological Therapeutics and Vaccines
ATCC and USP launch six new products that can be used to detect residual host cell genomic DNA (gDNA)
ATCC Announces New Award from BARDA to Further Support its Medical Countermeasures Clinical Studies Network
ATCC announced task order award from BARDA to serve as a centralized facility to support the storage and distribution of clinical samples and investigational products.
March 21, 2023
ATCC Hires New Chief Financial Officer
As CFO, Mr. Boller will work with executive leadership to manage external reporting and auditing requirements, oversee major contracts, forecasting, budgeting of business operations, and serve as assistant treasurer of the Finance Committee of the Board of Directors.
February 23, 2023
ATCC and USP Enter Strategic Collaboration to Support Global Quality Production of Biologics
ATCC and USP announced a strategic collaboration to provide solutions and standards that help customers deliver safe and high-quality biologics to patients more rapidly.
January 10, 2023
ATCC Announces Participation with Areté on IARPA Contract to Develop New Methods for Identifying Low-dose Radiation Exposure
ATCC announced that it would be supporting Areté, one of the four winning teams awarded a contract from IARPA, to develop novel methods for Targeted Evaluation of Ionizing Radiation Exposure (TEI-REX).
